Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000593415 | SCV000702114 | likely pathogenic | not provided | 2016-12-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000593415 | SCV004295901 | likely pathogenic | not provided | 2023-02-16 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in unknown protein product impact (PMID: 20179744). ClinVar contains an entry for this variant (Variation ID: 497538). This variant has been observed in individual(s) with Stickler syndrome (PMID: 20179744; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 35 of the COL2A1 gene. It does not directly change the encoded amino acid sequence of the COL2A1 protein. It affects a nucleotide within the consensus splice site. |